EXTRACELL BIOTECHNOLOGIES
ActiveSummary
EXTRACELL BIOTECHNOLOGIES has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€8,397) and a net result of -€1,898. Equity is shrinking by about 106% per year across the filed financial years. Its solvency ranks better than 5% of 613 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “La recherche et développement,la promotion,l’achat et la vente de tous produits et/ou procédé biotechnologiques,biologie…” (deed in French)
Text of the purpose (deed in French)
“La recherche et développement,la promotion,l’achat et la vente de tous produits et/ou procédé biotechnologiques,biologie synthétique,pharmaceutiques,thérapeutiques,cosmétiques,diététiques,à usage humain,végétal,animal,biologiques,produits chimiques,de tous matériels et instruments médicaux et chirurgicaux.”
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- EXTRACELL BIOTECHNOLOGIES
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région wallonne, sièges administratifs,d'exploitation,agences et succursales tant en Belgique qu'à l'étranger par simple décision de…” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Collège d'administrateurs, moitié au moins membres présents ou représentés” (deed in French)
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Copie de l’offre, autres cessions et transmissions pour cause de décès soumises à peine de nullité” (deed in French)
- Share issue ruleHow and by whom new shares can be issued.
- “Actions non souscrites à nouveau offertes aux actionnaires ayant exercé totalité de leur droit en proportion de leurs actions jusqu’à…” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- “Article 21 Date Convocation L'assemblée générale ordinaire est tenue chaque année, soit au siège, soit en tout autre local désigné dans la…” (deed in French)
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- One provision in the deed
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- One provision in the deed